Yenew Kebede1, Peter N Fonjungo2, Gudeta Tibesso3, Ritu Shrivastava4, John N Nkengasong4, Thomas Kenyon2, Amha Kebede5, Renuka Gadde6, Gonfa Ayana5. 1. Centers for Disease Control and Prevention (CDC). 2. Centers for Disease Control and Prevention (CDC) CDC, Atlanta, Georgia. 3. International Center for AIDS Care and Treatment Programs, Columbia University. 4. CDC, Atlanta, Georgia. 5. Ethiopian Public Health Institute, Addis Ababa, Ethiopia. 6. Becton, Dickinson, and Company, Franklin Lakes, New Jersey.
Abstract
BACKGROUND: Nonstandardized specimen-transport logistics, lack of laboratory personnel to transport specimens, lack of standard specimen containers, and long turnaround time (TAT) hindered access to quality laboratory services. The objective of the Becton, Dickinson, and Company (BD)-US President's Emergency Plan for AIDS Relief (PEPFAR) Public-Private Partnership (PPP) was to support country-specific programs to develop integrated laboratory systems, services, and quality improvement strategies, with an emphasis on strengthening the specimen-referral system (SRS). METHODS: In 2007, through the Centers for Disease Control and Prevention (CDC), the Ethiopian Public Health Institute (EPHI) joined with the BD-PEPFAR PPP to strengthen laboratory systems. A joint planning and assessment committee identified gaps in the SRS for prioritization and intervention and piloted the system in Addis Ababa and Amhara Region. RESULTS: The PPP established standardized, streamlined specimen logistics, using the Ethiopian Postal Service Enterprise to support a laboratory network in which 554 facilities referred specimens to 160 laboratories. The PPP supported procuring 400 standard specimen containers and the training of 586 laboratory personnel and 81 postal workers. The average TAT was reduced from 7 days (range, 2-14 days) to 2 days (range, 1-3 days) in Addis Ababa and from 10 days (range, 6-21 days) to 5 days (range, 2-6 days) in Amhara Region. CONCLUSIONS: This study highlights the feasibility and untapped potential of PPPs to strengthen laboratory systems. This planned and structured approach to improving specimen referral enhanced access to quality laboratory services.
BACKGROUND: Nonstandardized specimen-transport logistics, lack of laboratory personnel to transport specimens, lack of standard specimen containers, and long turnaround time (TAT) hindered access to quality laboratory services. The objective of the Becton, Dickinson, and Company (BD)-US President's Emergency Plan for AIDS Relief (PEPFAR) Public-Private Partnership (PPP) was to support country-specific programs to develop integrated laboratory systems, services, and quality improvement strategies, with an emphasis on strengthening the specimen-referral system (SRS). METHODS: In 2007, through the Centers for Disease Control and Prevention (CDC), the Ethiopian Public Health Institute (EPHI) joined with the BD-PEPFAR PPP to strengthen laboratory systems. A joint planning and assessment committee identified gaps in the SRS for prioritization and intervention and piloted the system in Addis Ababa and Amhara Region. RESULTS: The PPP established standardized, streamlined specimen logistics, using the Ethiopian Postal Service Enterprise to support a laboratory network in which 554 facilities referred specimens to 160 laboratories. The PPP supported procuring 400 standard specimen containers and the training of 586 laboratory personnel and 81 postal workers. The average TAT was reduced from 7 days (range, 2-14 days) to 2 days (range, 1-3 days) in Addis Ababa and from 10 days (range, 6-21 days) to 5 days (range, 2-6 days) in Amhara Region. CONCLUSIONS: This study highlights the feasibility and untapped potential of PPPs to strengthen laboratory systems. This planned and structured approach to improving specimen referral enhanced access to quality laboratory services.
Authors: Larry E Westerman; Luciana Kohatsu; Astrid Ortiz; Bernice McClain; Jonathan Kaplan; Thomas Spira; Barbara Marston; Ilesh V Jani; John Nkengasong; Linda M Parsons Journal: Am J Clin Pathol Date: 2010-10 Impact factor: 2.493
Authors: John N Nkengasong; Tsehaynesh Mesele; Sherry Orloff; Yenew Kebede; Peter N Fonjungo; Ralph Timperi; Deborah Birx Journal: Am J Clin Pathol Date: 2009-06 Impact factor: 2.493
Authors: Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre Journal: N Engl J Med Date: 2008-11-20 Impact factor: 91.245
Authors: Peter Nsubuga; Okey Nwanyanwu; John N Nkengasong; David Mukanga; Murray Trostle Journal: BMC Public Health Date: 2010-12-03 Impact factor: 3.295
Authors: John N Nkengasong; Peter Nsubuga; Okey Nwanyanwu; Guy-Michel Gershy-Damet; Giorgio Roscigno; Marc Bulterys; Barry Schoub; Kevin M DeCock; Deborah Birx Journal: Am J Clin Pathol Date: 2010-09 Impact factor: 2.493
Authors: Wendy Mphatswe; Natasha Blanckenberg; Gareth Tudor-Williams; Andrew Prendergast; Christina Thobakgale; Nompumelelo Mkhwanazi; Noel McCarthy; Bruce D Walker; Photini Kiepiela; Philip Goulder Journal: AIDS Date: 2007-06-19 Impact factor: 4.177
Authors: Paul K Drain; Jienchi Dorward; Andrew Bender; Lorraine Lillis; Francesco Marinucci; Jilian Sacks; Anna Bershteyn; David S Boyle; Jonathan D Posner; Nigel Garrett Journal: Clin Microbiol Rev Date: 2019-05-15 Impact factor: 26.132
Authors: Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong Journal: Clin Microbiol Rev Date: 2018-11-28 Impact factor: 26.132
Authors: Carmen Hazim; Rajiha Abubeker Ibrahim; Matthew Westercamp; Gebrie Alebachew Belete; Berhanu Amare Kibret; Theresa Kanter; Getnet Yimer; Thuria Siraj Adem; Kurt B Stevenson; Maritza Urrego; Kashmira N Kale; Michael W Omondi; Daniel VanderEnde; Benjamin J Park; Michele M B Parsons; Kathleen M Gallagher Journal: Health Secur Date: 2018
Authors: Zelda R Moran; Atta B Frimpong; Pablo Castañeda-Casado; Francis K Frimpong; Manuela B de Lorenzo; Yanis Ben Amor Journal: Afr J Lab Med Date: 2019-09-26
Authors: David E Lowe; Gerald Pellegrini; Elizabeth LeMasters; Andrew J Carter; Zachary P Weiner Journal: PLoS One Date: 2020-04-17 Impact factor: 3.240